Our key to success: A vast diversity of data brought together in one unified platform and cutting edge machine learning.

We start our discovery journey where purely human reasoning reaches its limits. Our algorithms can operate in hundreds of dimensions of information combining proteomics, genomics, imaging, and patient data to predict new ways to cure disease. After thorough digital evaluation and de-risking, we test these hypotheses in our own proprietary disease models. Our approach is extremely versatile and lean as it does not require us to set up a laboratory before we have a list of high potential disease targets in hand.

Together with our partners we keep pushing the boundaries of technology to give hope to millions of patients and their families and develop the first treatments to cure Parkinson’s disease and other brain-aging diseases. We have entered the pre-clinical stage of our first AI-generated therapies.